| 1 |
34015137 | Innate Immune and Neuronal Genetic Markers Are Highly Predictive of Postoperative Pain and Morphine Patient-Controlled Analgesia Requirements in Indian but Not Chinese or Malay Hysterectomy Patients. | 2021 Nov 26 |
1 |
| 2 |
31967515 | OPRM1 and COMT polymorphisms: implications on postoperative acute, chronic and experimental pain after cardiac surgery. | 2020 Feb |
1 |
| 3 |
30709768 | Morphine biotransformation genes and neonatal clinical factors predicted behaviour problems in very preterm children at 18 months. | 2019 Feb |
1 |
| 4 |
29870475 | Severe and persistent morphine-induced respiratory depression associated with ATP-Binding Cassette Subfamily B Member 1 and catechol-O-methyltransferase genetic defects: A case report. | 2018 Jul |
1 |
| 5 |
28084056 | Genetic Influences of OPRM1, OPRD1 and COMT on Morphine Analgesia in a Multi-Modal, Multi-Tissue Human Experimental Pain Model. | 2017 Jul |
4 |
| 6 |
28928973 | Prospective replication study implicates the catechol-O-methyltransferase Val158Met polymorphism as a biomarker for the response to morphine in patients with cancer. | 2017 Oct |
5 |
| 7 |
28985716 | Selection of opioids for cancer-related pain using a biomarker: a randomized, multi-institutional, open-label trial (RELIEF study). | 2017 Oct 6 |
5 |
| 8 |
29259946 | Genetic Analysis of Mu and Kappa Opioid Receptor and COMT Enzyme in Cancer Pain Tunisian Patients Under Opioid Treatment. | 2017 Dec |
1 |
| 9 |
25963335 | Common variants of catechol-O-methyltransferase influence patient-controlled analgesia usage and postoperative pain in patients undergoing total hysterectomy. | 2016 Apr |
1 |
| 10 |
26902643 | Human Genetic Variability Contributes to Postoperative Morphine Consumption. | 2016 May |
1 |
| 11 |
27288213 | Association of the OPRM1 and COMT genes' polymorphisms with the efficacy of morphine in Tunisian cancer patients: Impact of the high genetic heterogeneity in Tunisia? | 2016 Oct |
1 |
| 12 |
26678969 | Clinical Implications of Opioid Pharmacogenomics in Patients With Cancer. | 2015 Oct |
1 |
| 13 |
24533707 | Genetics of pain perception, COMT and postoperative pain management in children. | 2014 Feb |
1 |
| 14 |
25155931 | Rescue morphine in mechanically ventilated newborns associated with combined OPRM1 and COMT genotype. | 2014 Jul |
4 |
| 15 |
23210659 | The Val158Met polymorphism of the COMT gene is associated with increased pain sensitivity in morphine-treated patients undergoing a painful procedure after cardiac surgery. | 2013 Jun |
3 |
| 16 |
23686330 | Genetic variability at COMT but not at OPRM1 and UGT2B7 loci modulates morphine analgesic response in acute postoperative pain. | 2013 Sep |
4 |
| 17 |
23773341 | An opposite-direction modulation of the COMT Val158Met polymorphism on the clinical response to intrathecal morphine and triptans. | 2013 Oct |
3 |
| 18 |
22293824 | Expression changes in arrestin β 1 and genetic variation in catechol-O-methyltransferase are biomarkers for the response to morphine treatment in cancer patients. | 2012 May |
5 |
| 19 |
21127283 | Combined catechol-O-methyltransferase and mu-opioid receptor gene polymorphisms affect morphine postoperative analgesia and central side effects. | 2011 Feb |
3 |
| 20 |
19912274 | Dopamine, morphine, and nitric oxide: an evolutionary signaling triad. | 2010 Jun |
1 |
| 21 |
20150871 | Variations in critical morphine biosynthesis genes and their potential to influence human health. | 2010 |
1 |
| 22 |
22371762 | Catechol-O-methyltransferase: potential relationship to idiopathic hypertension. | 2010 Jun 30 |
2 |
| 23 |
17573783 | Endogenous morphine signaling via nitric oxide regulates the expression of CYP2D6 and COMT: autocrine/paracrine feedback inhibition. | 2008 Mar |
4 |
| 24 |
17722074 | Pharmacogenetics of morphine: Potential implications in sickle cell disease. | 2008 Mar |
1 |
| 25 |
18257092 | Genetic variation and response to morphine in cancer patients: catechol-O-methyltransferase and multidrug resistance-1 gene polymorphisms are associated with central side effects. | 2008 Mar 15 |
2 |
| 26 |
18370847 | Genetic mutations that prevent pain: implications for future pain medication. | 2008 Feb |
1 |
| 27 |
19094200 | Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain. | 2008 Dec 18 |
3 |
| 28 |
17156920 | Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. | 2007 Jul |
5 |
| 29 |
17982691 | Endogenous morphine synthetic pathway preceded and gave rise to catecholamine synthesis in evolution (Review). | 2007 Dec |
1 |
| 30 |
15927391 | The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients. | 2005 Jul |
4 |
| 31 |
16045647 | Genetic variability and clinical efficacy of morphine. | 2005 Aug |
2 |
| 32 |
16215614 | [Genetic variation-- important for the clinical effect of opioids?]. | 2005 Oct 6 |
1 |